Skip to content
Biotechnology Innovation Organization (BIO) member companies and CEOs sent a letter to congressional leaders urging them to pass the bipartisan ORPHAN Cures Act and […]
CEOs ask Congress to pass ORPHAN Cures Act Read More »
Artificial intelligence and machine learning have boosted drug development and enhanced the value of biotech firms for years, but investors and companies need to
Drug developers and investors need to join AI revolution, panel says Read More »
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
Rare Disease Week 2024, taking place February 25–28, is an important annual reminder of the need to find cures and improve therapies for patients.
Rare Disease Week 2024: standing up for 1 in 10 Americans Read More »
The Biotechnology Innovations Organization (BIO) report, The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases, on January 25, 2024, found that
CEOs explore challenges and opportunities in vaccine pipeline Read More »
The science of gene therapies is progressing at a remarkable pace, but if these medicines are going to reach patients, trends in investment and
CEOs say market must keep up with the science of gene therapies Read More »
The New York City Economic Development Corporation (NYCEDC) announced on February 26 that it’s seeking a private-sector anchor tenant for the Science Park and
NYCEDC seeks private-sector life sciences anchor tenant at SPARC Kips Bay Read More »
As the 13th Ministerial Conference of the World Trade Organization (WTO) kicks off (Feb. 26-29), the expansion of the COVID-19 IP waiver remains a
Why the WTO should focus on addressing trade-related aspects of pandemic preparedness Read More »
On February 21, the Biotechnology Innovation Organization’s (BIO) soon-to-be President & CEO, John F. Crowley, joined an event about biomarkers and rare disease regulatory
How biomarkers can support regulatory rare disease pathways Read More »
The Covid-19 pandemic undoubtedly reshaped the landscape of healthcare and vaccine development in ways we have yet to imagine. As we navigate through another
The future of pandemic defense leverages science and tech Read More »
